Overview:
- Toujeo is a basal insulin administered once a day.
- It is injected with a pre-filled pen.
- Scientific name: Glargine, which is the same active ingredient found in Lantus insulin.
- It is recommended for patients requiring high doses of long-acting insulin.
- For patients with type 1 diabetes, Toujeo must be taken with another type of fast-acting insulin, according to the doses and timing prescribed by the doctor.
- Type 2 diabetes patients can take it with other oral medications.
Difference between Toujeo and Lantus:
| Toujeo insulin
| Lantus insulin
|
Total units per pen
| 450 units
| 300 units
|
Concentration
| 300 units / mL
| 100 units / mL
|
Onset of action
| Within 6 hours
| Within 3-4 hours
|
Switching from other basal insulins to Toujeo:
- If you are switching from Lantus or any once-daily (long-acting) basal insulin to Toujeo:
- For patients with type 1 diabetes, Toujeo must be taken with another type of fast-acting insulin, according to the doses and timing prescribed by the doctor.
- If you are switching from twice-daily basal insulin (intermediate acting insulin) to once-daily Toujeo:
- The recommended initial Toujeo dose should be 80% of the total daily dose of basal insulin that is being discontinued.
Notes:
These changes should be made cautiously and only under medical supervision. It is also important to increase the number of times you measure your blood sugar levels in the beginning.
Patients with type 2 diabetes may need to change the dosage of their oral medications.
Clinical Education General Department
For inquiries, contact us by e-mail.
